Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated clostridium difficile infection

Infection Control and Hospital Epidemiology

Volumn 31, Issue 7, 2010, Pages 710-715

  Miller, Mark ^a   Bernard, Lisa ^b   Thompson, Melissa ^b   Grima, Daniel ^b   Pepin, Jocelyne ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Department of Data Analytics and Evidence Synthesis   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

AGED; ARTICLE; BACTERIAL COLONIZATION; CANADA; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; FEMALE; HEALTH CARE; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECTS; ENTEROCOCCUS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EPIDEMIC; GROWTH, DEVELOPMENT AND AGING; INCIDENCE; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; STATISTICS AND NUMERICAL DATA; UNIVERSITY HOSPITAL;

AGED; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DISEASE OUTBREAKS; ENTEROCOCCUS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MALE; QUEBEC; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 77953848554     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/653613     Document Type: Article

References (14)

1. Loo VG, Poirier L, Miller M, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353(23):2442-2449.
2. Pépin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171(5):466-472.
3. Bonten MJ, Willems R, Weinstein RA. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1(5):314-325.
4. Shin JW, Yong D, Kim MS, et al. Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin. J Infect Chemother 2003;9(1): 62-67.
5. Moreno A, del Rio A, Pereda D, et al. Vancomycin-resistant Enterococcus faecium during a nosocomial outbreak of Clostridium difficile diarrhea. Int J Antimicrob Agents 2007;29(suppl 2):S165. Abstract P687.
6. Poutanen SM, Simor S. Clostridium difficile-associated diarrhea in adults. CMAJ 2004;171(1):51-58.
7. Ballard SA, Grabsch EA, Johnson PD, Grayson ML. Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli. Antimicrob Agents Chemother 2005; 49(1):77-81.
8. Mak A, Miller M, Chong G, Monczak Y. Comparison of PCR and culture for screening of vancomycin-resistant enterococci: highly disparate results for VanA and VanB. J Clin Microbiol 2009;47(12):4136-4137.
9. Al-Nassir W, Sethi AK, Li Y, Pultz MJ, Riggs MM, Donskey CJ. Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease. Antimicrob Agents Chemother 2008;52(7):2403-2406.
10. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45(3):302-307.
11. Louie TJ, Gerson M, Grimard D, et al. Results of a phase III study comparing tolevamer, vancomycin and metronidazole in Clostridium difficile-associated diarrhea. In: Program and abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 2007. Abstract K425a.
12. Teasley DG, Gerding DN, Olson MM, et al. Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis. Lancet 1983;2(8358):1043-1046.
13. Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996;22(5):813-818.
14. Gerding DN. Metronidazole for Clostridium difficile-associated disease: is it okay for mom? Clin Infect Dis 2005;40(11):1598-1600.